FIELD: medicine.
SUBSTANCE: composition contains phospholipids in the form of liposomes with the average particle size 0.05-0.22 mcm that are presented by phosphatidylcholine and/or cardiolipin, sulphated glycosaminoglycans in the form of keratan sulphate sodium salt and chondroitin sulphate sodium salt, a hypotensive preparation. Sulphated glycosaminoglycans and the hypotensive preparation are integrated into the liposomes, and placed outside the liposomes in a physiological solution. The composition additionally contains Oleamide, lisocyme and albumin. The ingredients are used in the declared amounts.
EFFECT: using the invention enables forming a protective layer of the lubricant on the ocular surface, reducing lachrymal film evaporation, normalising metabolic processes in the corneal epithelial cells that intensifies regenerative processes in the ocular surface structures.
7 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR INTEGRATED TREATMENT OF PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AND OCULAR SURFACE DISEASES | 2011 |
|
RU2464985C1 |
PHARMACEUTICAL COMPOSITION FOR INTEGRATED TREATMENT OF OCULAR SURFACE DISEASES IN PATIENTS SUFFERING PRIMARY OPEN-ANGLE GLAUCOMA | 2011 |
|
RU2460517C1 |
EYE DROPS FOR TREATING DRY EYE SYNDROME | 2006 |
|
RU2302231C1 |
DRAIN TUBE FOR OPHTHALMIC OPERATIONS | 2015 |
|
RU2585728C1 |
METHOD OF TREATING BLEPHAROCONJUNCTIVAL FORM OF DRY EYE SYNDROME | 2012 |
|
RU2510701C1 |
METHOD OF TREATING DRY EYE SYNDROME | 2015 |
|
RU2581495C1 |
GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
METHOD FOR CHOOSING PATHOGENETICALLY CAUSED THERAPEUTIC APPROACH TO VIRAL OCULAR DISEASES | 2012 |
|
RU2494741C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF GEL-LIKE OPHTHALMIC DROPS FOR TREATING GLAUCOMA | 2015 |
|
RU2576778C1 |
METHOD OF PREVENTING SCARRING AFTER ANTIGLAUCOMA OPERATIONS WITH APPLICATION OF DENERVATION PRINCIPLE | 2010 |
|
RU2436551C1 |
Authors
Dates
2014-05-27—Published
2013-03-05—Filed